Study of a Respiratory Syncytial Virus/Human Metapneumovirus/Parainfluenza Virus Type 3 Vaccine Candidate in Adults Aged 60 Years and Older

Clinical trial NCT06604767 · COMPLETED

Trial details

NCT number: NCT06604767
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infection Metapneumovirus Infection Parainfluenzae Virus Infection

Start date: 2024-09-17
Primary completion: 2026-03-24
Enrollment: 390

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.